Observational studyMedicine2026

Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease.

Cheng Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.